Year archive

PharmaSGP Holding SE — 2021 filings

All 36 regulatory filings released by PharmaSGP Holding SE (PSG) in 2021, sourced directly from the official regulator.

36 Filings

2021 Period

2021 filings (36)

Filing	Released	Lang
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-12-07	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-12-07	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-12-02	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-12-02	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-12-02	English
Q3 statement / Q3 financial report 2021 Interim / Quarterly Report Q3 2021	2021-11-30	German
PharmaSGP reporting 34% revenue growth and increased profitability in Q3 2021 Earnings Release 9M 2021	2021-11-16	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-18	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-10-18	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-10-18	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-10-18	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-10-12	English
Half-yearly financial report 2021 Interim / Quarterly Report FY 2021	2021-09-30	German
Report Publication Announcement 2021 Report Publication Announcement	2021-09-29	English
PharmaSGP: Product portfolio further expanded and internationalisation driven forward in H1 2021 Earnings Release H1 2021	2021-09-16	English
PharmaSGP Holding SE raises forecast for FY 2021 following completion of acquisition of OTC brand portfolio Regulatory Filings	2021-09-15	English
PharmaSGP Group completes acquisition of OTC brand portfolio (Baldriparan, Formigran, Spalt and Kamol) from GSK M&A Activity	2021-08-31	English
PharmaSGP Holding SE: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution Regulatory Filings	2021-08-27	English
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-07-12	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-07-07	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-07-07	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-06-28	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-06-28	English
PharmaSGP successfully holds first AGM after IPO AGM Information	2021-06-25	English
PharmaSGP Group acquires OTC brand portfolio (Baldriparan, Formigran, Spalt and Kamol) from GSK M&A Activity	2021-06-15	English
Q1 statement / Q1 financial report 2021 Interim / Quarterly Report Q1 2021	2021-05-27	German
PharmaSGP: Expected business development in Q1 2021 Earnings Release Q1 2021	2021-05-18	English
PharmaSGP Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 24.06.2021 in ir.pharmasgp.com/#Hauptversammlung mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2021-05-12	German
Declaration of Voting Results & Voting Rights Announcements 2021 Declaration of Voting Results & Voting Rights Announcements	2021-05-11	English
Jahresfinanzbericht 2020 (PDF) Annual Report FY 2020	2021-05-04	German
Annual financial report 2020 (PDF) Annual Report FY 2020	2021-04-29	English
Report Publication Announcement 2021 Report Publication Announcement	2021-04-19	English
Report Publication Announcement 2021 Report Publication Announcement	2021-04-16	English
PharmaSGP: Revenue growth in 2020 despite declining markets Earnings Release FY 2020	2021-03-31	English
DGAP-DD: PharmaSGP Holding SE english Director's Dealing	2021-02-19	English
PharmaSGP Holding SE announces preliminary FY 2020 revenue and earnings trends after suspension of forecast Earnings Release FY 2020	2021-02-11	English